Access barriers to the use of innovative technology such as administrative burden and reimbursement challenges. We will also touch upon payer concern about costs which might be underlying these issues.
- Barrier to uptake of cell and gene therapies
- Reimbursement challenges with cell/gene therapies
- Payer interest in alternative contracts for cell/gene therapies
- Payer coverage of genetic testing and perception of administrative burden
- Use and coverage of telemedicine in the wake of COVID-19